Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-assisted treatment for alcohol dependence
NCT02061293Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2014
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of psilocybin in alcohol dependence, sponsored by NYU Langone Health. Primary endpoint: Percent Heavy Drinking Days. Started Jun 2014; status: completed.
02
Drugs
psilocybin
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT02061293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061293.